Beksaç Kemal, Aktoz Fatih, Örgül Gökçen, Çelik Hasan Tolga, Özgü-Erdinç A Seval, Beksaç M Sinan
Clinic of General Surgery, University of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey
Division of Perinatology, Department of Obstetrics and Gynecology, Hacettepe University School of Medicine, Ankara, Turkey
J Turk Ger Gynecol Assoc. 2018 Jun 4;19(2):94-97. doi: 10.4274/jtgga.2017.0057. Epub 2018 Feb 20.
To evaluate “papillary thyroid carcinoma-pregnancy” interaction among cancer survivors.
The clinical records of 8 pregnant women who received treatment for papillary thyroid cancer before their pregnancy were evaluated. Clinical features, pregnancy/perinatal outcomes and high-risk factors were compared with 45 controls who were randomly assigned from the institutional perinatal medicine database.
Patients in the cancer group were older than the control group (34.3 vs 29.8 years). The cesarean section rate was higher (62.5% vs 33.3%) and the APGAR scores at the 1 and 5 minutes were lower in the cancer group.
Management of pregnancies with papillary thyroid cancer treatment and follow-up requires a multidisciplinary approach with careful antenatal care and perinatal surveillance. Patients who have received papillary thyroid cancer treatment can safely undergo pregnancy.
评估癌症幸存者中“甲状腺乳头状癌-妊娠”的相互作用。
对8例在妊娠前接受过甲状腺乳头状癌治疗的孕妇的临床记录进行评估。将临床特征、妊娠/围产期结局及高危因素与从机构围产医学数据库中随机选取的45例对照进行比较。
癌症组患者年龄大于对照组（34.3岁对29.8岁）。癌症组剖宫产率更高（62.5%对33.3%），且1分钟和5分钟时的阿氏评分更低。
甲状腺乳头状癌治疗及随访的妊娠管理需要多学科方法，包括仔细的产前护理和围产期监测。接受过甲状腺乳头状癌治疗的患者可以安全妊娠。
